Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000694652 | SCV000823109 | pathogenic | Rett syndrome, congenital variant | 2018-04-24 | criteria provided, single submitter | clinical testing | This sequence change results in a premature translational stop signal in the FOXG1 gene (p.Tyr341*). While this is not anticipated to result in nonsense mediated decay, it is expected to delete the last 149 amino acids of the FOXG1 protein. This variant is not present in population databases (ExAC no frequency). This variant is observed to be de novo in an individual with clinical features consistent with FOXG1-related disease (Invitae). A different truncation (p.Tyr400*) that lies downstream of this variant has been determined to be pathogenic (PMID: 19564653, 19806373). This suggests that deletion of this region of the FOXG1 protein is causative of disease. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000694652 | SCV000893350 | pathogenic | Rett syndrome, congenital variant | 2018-10-31 | criteria provided, single submitter | clinical testing |